FX.co ★ NeuroBo Pharmaceuticals, Inc. Q2 Loss Increases, Misses Estimates

NeuroBo Pharmaceuticals, Inc. (NRBO) reported a significant increase in its second-quarter loss compared to the previous year, failing to meet Wall Street expectations.

The company's net loss for the quarter was $10.05 million, or $1.85 per share, compared to a loss of $0.73 million, or $0.15 per share, in the same quarter last year.

Analysts, based on data from Thomson Reuters, had anticipated a loss of $1.12 per share on average. It’s important to note that these projections typically exclude special items.

Key financial highlights for NeuroBo Pharmaceuticals, Inc. (GAAP):

- Quarterly Earnings (Q2): Loss of $10.05 million vs. loss of $0.73 million last year.

- Earnings Per Share (EPS, Q2): Loss of $1.85 vs. loss of $0.15 last year.